|Articles|March 30, 2022
A streamlined drug-to-antibody ratio determination workflow for intact and deglycosylated antibody-drug conjugates
Author(s)Agilent Technologies, Inc.
Related Content
Trending on LCGC International
1
How AI and Machine Learning Are Reshaping Separations Science at HPLC 2026
2
ASMS 2026 Award Winners Highlight the Future of Mass Spectrometry
3
Hyphenated Chromatography Methods: Successes and Remaining Challenges
4
ASMS 2026: Phantom Metabolites and the Hidden Chemistry of Electrospray Ionization
5